Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Bjermer

Showing results (21-30 of 272) with videos related to

Pageof 28
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|May 26, 2015
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammationEllen Tufvesson, Leif Bjermer, Marie Ekberg
Drug Design, Development and Therapy|September 14, 2016
Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthmaPiotr Kuna, Leif Bjermer, Göran Tornling
Respiratory Medicine|November 1, 2011
Extended diagnostic criteria used for indirect challenge testing in elite asthmatic swimmersKerstin Romberg, Ellen Tufvesson, Leif Bjermer
Expert Review of Clinical Immunology|May 19, 2010
Montelukast in the treatment of asthma and beyondZuzana Diamant, Eva Mantzouranis, Leif Bjermer
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 28, 2017
Sex differences in asthma in swimmers and tennis playersKerstin Romberg, Ellen Tufvesson, Leif Bjermer
European Clinical Respiratory Journal|September 14, 2020
Clinical and daily respiratory care and clinical trials within the COVID-19 eraZuzana Diamant, Vibeke Backer, Leif Bjermer
Pulmonary Pharmacology & Therapeutics|June 17, 2019
Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthmaLeif Bjermer, Katharine Abbott-Banner, Kenneth Newman
American Journal of Respiratory Cell and Molecular Biology|June 21, 2003
Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthmaYiqing Cai, Leif Bjermer, Trond S Halstensen
Respiratory Medicine|December 7, 2007
Methods used in clinical development of novel anti-asthma therapiesZuzana Diamant, Diderik Boot, Ingrid Kamerling, et al.
Current Opinion in Pulmonary Medicine|November 18, 2015
Revisiting the role of the mast cell in asthmaCecilia Andersson, Ellen Tufvesson, Zuzana Diamant, et al.
Pageof 28

Showing results (21-30 of 272) with videos related to

Sort By:
Pageof 28
International Journal of Chronic Obstructive Pulmonary Disease|May 26, 2015
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammationEllen Tufvesson, Leif Bjermer, Marie Ekberg
Drug Design, Development and Therapy|September 14, 2016
Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthmaPiotr Kuna, Leif Bjermer, Göran Tornling
Respiratory Medicine|November 1, 2011
Extended diagnostic criteria used for indirect challenge testing in elite asthmatic swimmersKerstin Romberg, Ellen Tufvesson, Leif Bjermer
Expert Review of Clinical Immunology|May 19, 2010
Montelukast in the treatment of asthma and beyondZuzana Diamant, Eva Mantzouranis, Leif Bjermer
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 28, 2017
Sex differences in asthma in swimmers and tennis playersKerstin Romberg, Ellen Tufvesson, Leif Bjermer
European Clinical Respiratory Journal|September 14, 2020
Clinical and daily respiratory care and clinical trials within the COVID-19 eraZuzana Diamant, Vibeke Backer, Leif Bjermer
Pulmonary Pharmacology & Therapeutics|June 17, 2019
Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthmaLeif Bjermer, Katharine Abbott-Banner, Kenneth Newman
American Journal of Respiratory Cell and Molecular Biology|June 21, 2003
Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthmaYiqing Cai, Leif Bjermer, Trond S Halstensen
Respiratory Medicine|December 7, 2007
Methods used in clinical development of novel anti-asthma therapiesZuzana Diamant, Diderik Boot, Ingrid Kamerling, et al.
Current Opinion in Pulmonary Medicine|November 18, 2015
Revisiting the role of the mast cell in asthmaCecilia Andersson, Ellen Tufvesson, Zuzana Diamant, et al.
Pageof 28